| Element List | Explanation |
|---|---|
| Introduction | Lana Company announces the Board of Directors' recommendation to distribute cash dividends to shareholders for the fiscal year ending 31/12/2025 |
| Date of the board’s recommendation | 2026-03-26 Corresponding to 1447-10-07 |
| The Total amount distributed | 1,620,000.00 |
| Number of Shares Eligible for Dividends | 54,000,000 |
| Dividend per share | 0.03 |
| Percentage of Dividend to the Share Par Value (%) | 3 |
| Eligibility date | Following the General Assembly's approval of this recommendation, the entitlement to profits will be for the company's shareholders who own shares at the close of trading on the day of the General Assembly meeting and are registered in the company's records at the Securities Depository Center Company (Edaa) by the end of the second trading day following the date of the General Assembly meeting, the date of which will be announced later after obtaining the necessary official approvals. |
| Distribution Date | It will be determined later in accordance with the relevant regulatory controls and procedures |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | Not applicable |
| Additional Information | It is worth noting that these distributions are in line with Lana's commitment to achieving sustainable returns for its shareholders annually while maintaining the necessary financial flexibility to support its growth strategy. Lana would like to draw the attention of non-resident foreign investors to the fact that cash distributions transferred through a resident financial intermediary are subject to a 5% withholding tax upon transfer or crediting to their account, in accordance with Article (68) of the Tax Law and Article (63) of its Implementing Regulations. The company urges its valued shareholders to update their information and ensure that their bank account numbers are linked to their investment portfolios to guarantee the timely receipt of their dividends. We welcome your inquiries or comments through the Investor Relations Department via the following contact methods: 0555801796 IR@lanamedical.com |